Drug Shortage Report for ONCOTICE
Report ID | 63600 |
Drug Identification Number | 02153513 |
Brand name | ONCOTICE |
Common or Proper name | Bacillus Calmette- Guérin (BCG), strain TICE powder for solution |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BACILLUS CALMETTE-GUERIN |
Strength(s) | 800000000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVESICAL |
Packaging size | 1 vial |
ATC code | L03AX |
ATC description | IMMUNOSTIMULANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-10-19 |
Actual start date | 2018-10-19 |
Estimated end date | 2027-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-02-18 |
Company comments | Manufacturing capacity constraints. Product is under allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2019-03-08 | English | Compare |
v8 | 2018-10-20 | French | Compare |
v7 | 2018-10-18 | English | Compare |
v6 | 2018-10-18 | French | Compare |
v5 | 2018-10-18 | English | Compare |
v4 | 2018-10-09 | French | Compare |
v3 | 2018-10-09 | English | Compare |
v2 | 2018-10-09 | French | Compare |
v1 | 2018-10-09 | English | Compare |